DELVINO, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 3.918
NA - Nord America 3.578
EU - Europa 1.965
SA - Sud America 744
Continente sconosciuto - Info sul continente non disponibili 259
AF - Africa 96
OC - Oceania 19
Totale 10.579
Nazione #
US - Stati Uniti d'America 3.399
SG - Singapore 1.027
IT - Italia 942
CN - Cina 744
VN - Vietnam 702
BR - Brasile 551
HK - Hong Kong 504
RU - Federazione Russa 349
JP - Giappone 192
BD - Bangladesh 186
FR - Francia 130
KR - Corea 119
IN - India 104
GB - Regno Unito 100
CA - Canada 91
DE - Germania 90
AR - Argentina 74
TR - Turchia 67
SE - Svezia 62
ES - Italia 61
ID - Indonesia 51
IQ - Iraq 44
MX - Messico 41
NL - Olanda 34
CO - Colombia 32
PK - Pakistan 27
VE - Venezuela 27
UA - Ucraina 26
ZA - Sudafrica 26
EC - Ecuador 25
FI - Finlandia 25
SA - Arabia Saudita 24
CH - Svizzera 23
IE - Irlanda 20
PL - Polonia 20
UZ - Uzbekistan 18
AU - Australia 16
AT - Austria 14
KE - Kenya 13
MA - Marocco 13
CL - Cile 12
CR - Costa Rica 12
PH - Filippine 12
TW - Taiwan 12
BE - Belgio 11
EG - Egitto 10
TH - Thailandia 10
JM - Giamaica 9
LB - Libano 9
AL - Albania 8
AZ - Azerbaigian 8
MY - Malesia 8
PE - Perù 7
TN - Tunisia 7
UY - Uruguay 7
ET - Etiopia 6
GR - Grecia 6
HR - Croazia 6
IL - Israele 6
NI - Nicaragua 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
CY - Cipro 5
DZ - Algeria 5
LT - Lituania 5
NP - Nepal 5
PA - Panama 5
PY - Paraguay 5
SY - Repubblica araba siriana 5
BO - Bolivia 4
BY - Bielorussia 4
HN - Honduras 4
JO - Giordania 4
KZ - Kazakistan 4
LV - Lettonia 4
PT - Portogallo 4
QA - Qatar 4
AO - Angola 3
CZ - Repubblica Ceca 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
SN - Senegal 3
CI - Costa d'Avorio 2
GE - Georgia 2
NO - Norvegia 2
OM - Oman 2
PR - Porto Rico 2
RE - Reunion 2
TT - Trinidad e Tobago 2
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
Totale 10.303
Città #
Singapore 564
Hong Kong 494
Ashburn 422
San Jose 417
Milan 280
Hefei 243
Ho Chi Minh City 216
Hanoi 202
Los Angeles 134
Council Bluffs 115
Seoul 114
Dallas 111
Rome 93
Beijing 90
New York 87
The Dalles 83
Chicago 81
Santa Clara 79
Ann Arbor 60
Tokyo 60
Lauterbourg 51
Turin 50
Moscow 45
Buffalo 44
São Paulo 44
Toronto 40
Columbus 38
Shanghai 37
Jakarta 32
Da Nang 25
Paris 24
San Francisco 23
Frankfurt am Main 22
Madrid 22
Orem 22
Phoenix 22
Rio de Janeiro 21
Atlanta 20
Boardman 20
Dublin 20
Biên Hòa 19
Florence 19
Denver 18
Haiphong 18
London 18
Montreal 18
Osaka 18
Ankara 17
Figino 17
Quận Bình Thạnh 17
Seattle 17
Tashkent 17
Baghdad 16
Guangzhou 16
Belo Horizonte 14
Bogotá 14
Brooklyn 14
Boston 13
Brasília 13
Caracas 13
Chennai 13
Hải Dương 13
Istanbul 13
Mexico City 13
Nuremberg 13
Riyadh 13
Stockholm 13
Amsterdam 12
Buenos Aires 12
Houston 12
Johannesburg 12
Princeton 12
Quito 12
Charlotte 11
Fairfield 11
Kent 11
Lappeenranta 11
Mumbai 11
Newark 11
Ryōke 11
Salt Lake City 11
Verona 11
Washington 11
Wilmington 11
Carate Brianza 10
Nairobi 10
Salvador 10
Warsaw 10
Bologna 9
Dhaka 9
Manchester 9
Munich 9
San José 9
Vienna 9
Baltimore 8
Brescia 8
Brussels 8
Chandler 8
Ha Long 8
Helsinki 8
Totale 5.319
Nome #
Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control study 640
Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group 613
Systemic vasculitis: one year in review 2024 325
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 310
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles 273
Systemic vasculitis: one year in review 2025 270
Approccio innovativo agli unmet needs nella gestione a lungo termine dei pazienti affetti da vasculite ANCA-associata 264
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study 258
Novel insights into the management of rheumatoid arthritis: one year in review 2024 237
Systemic vasculitis: one year in review 2022 216
Humoral and T-cell immune response following three doses of SARS-CoV-2 mRNA vaccine in giant cell arteritis: analysis of a prospective cohort 211
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis 198
Clinical outcomes of subglottic stenosis in granulomatosis with polyangiitis: results of an international multicentre observational study 189
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study 188
Factors influencing patient-reported outcomes in ANCA-associated vasculitis: correlates of the Patient Global Assessment 186
Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual 175
Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: A prospective analysis 174
Clinical picture, outcomes and predictors of relapse in eosinophilia-associated coronary vasospasm: data from a European multicentric study 173
A 28-Year-Old Man with Stridor and Dyspnea 171
Clinical Image: Extensive subcutaneous calcinosis cutis with fistulization in refractory dermatomyositis 165
Nivolumab and ipilimumab-induced eosinophilic granulomatosis with polangiitis in a patient treated with dupilumab 165
One year in review 2020: vasculitis 165
Azathioprine vs methotrexate in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective study 163
Current management of eosinophilic granulomatosis with polyangiitis across Europe: insights from a multinational expert survey 162
Asma, EGPA, HES: elementi di diagnostica differenziale 155
Massive abdominal haemorrhage due to sequential omental vasculitis and ruptured aneurysms in a patient with granulomatosis with polyangiitis 152
Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target 148
Asma ed ipereosinofilia 146
The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis: report of two cases and review of the literature 143
Impact of mepolizumab on patient-reported outcomes in eosinophilic granulomatosis with polyangiitis by using the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire 142
Set the scene: Key points dell’Inquadramento e diagnosi differenziale dell’EGPA 142
Novel Therapies for ANCA-associated Vasculitis 139
Long-term maintenance of remission with spacing of rituximab infusions based on the individualised patient risk profile in ANCA-associated vasculitis: a pilot study 136
Fast-Track Ultrasound Clinic for the Diagnosis of Giant Cell Arteritis Changes the Prognosis of the Disease but Not the Risk of Future Relapse 135
Quale approccio diagnostico al paziente con iper-eosinofilia? 135
The role of trimethoprim/sulfametoxazole in reducing relapses and risk of infections in ANCA-associated vasculitis: a meta-analysis 134
Safety of BNT162b2 mRNA COVID-19 vaccine in a cohort of elderly, immunocompromised patients with systemic vasculitis 133
Severe immunoglobulin A vasculitis with refractory gastrointestinal involvement in an adult patient successfully treated with plasma exchange 129
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 128
Update on Treatment of Antisynthetase Syndrome: A Brief Review 125
Systemic vasculitis: one year in review 2023 124
Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis 122
A New Era for the Early and Non‐Invasive Diagnosis of Giant Cell Arteritis: The Use of Fast‐Track Ultrasound in Clinical Practice 120
Early detection and risk stratification in autoimmune-related interstitial lung disease: a state-of-the-art review 118
Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis 116
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies 113
ANCA-Associated Vasculitides and Polyarteritis Nodosa - EULAR on-line course on Rheumatic Diseases 110
Prevalence of Whipple's disease in north-western Italy 110
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 109
Beyond Oral Anticoagulants Two case reports of Biopsy-Proven Heparin-Induced Anticoagulant-Related Nephropathy 107
Impact of delayed diagnoses at the time of COVID-19: Increased rate of preventable bilateral blindness in giant cell arteritis 107
Impact of immunosuppressive treatment on the immunogenicity of mRNA COVID-19 vaccine in vulnerable patients with giant cell arteritis 104
Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs' 102
Lumbar spondylolisthesis associated with systemic sclerosis-related spinal calcinosis: an unusual clinical case 99
One year in review 2021: Systemic vasculitis 97
Is it really infective endocarditis? Distinguishing systemic vasculitis from its mimics 97
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 96
Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter study 96
Striking abdominal aortic stenosis revealing Takayasu's arteritis 90
An unusual reno-pulmonary complication in the course of systemic sclerosis 89
Asma e poliposi nasale: quando preoccuparsi? 89
Erratum: Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis (Rheumatology (2020) 59 (e125-e127) DOI: 10.1093/rheumatology/keaa184) 89
Systemic vasculitis: one year in review 2026 72
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study 51
Addressing unmet needs in uncontrolled asthma through a specialized severe asthma center 38
Real-World Effectiveness and Safety of Secukinumab in Giant Cell Arteritis: An Italian Multicenter Cohort Study 1
Totale 10.579
Categoria #
all - tutte 32.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.217


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202265 0 0 0 11 14 8 10 1 3 4 4 10
2022/202372 8 18 6 2 3 12 8 5 7 0 3 0
2023/2024355 0 1 5 5 8 12 12 1 133 11 50 117
2024/20252.863 155 274 68 113 170 99 197 85 224 340 302 836
2025/20265.299 623 482 440 565 352 240 671 280 424 466 277 479
2026/20271.859 352 577 860 70 0 0 0 0 0 0 0 0
Totale 10.579